ACTRN12610000803099尚未招募未知
The Effect of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) on Overall Survival of Patients with Relapsed Diffuse Large B-Cell Lymphoma Post-Autologous Stem Cell Transplant
Haematology and Oncology Clinics (HOCA) Research Centre0 个研究点目标入组 150 人开始时间: 2010年9月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Patients with histologically-confirmed DLBCL
- •Must have received CHOP (CHOP 14, CHOP 21) or R-CHOP (R-CHOP 14, R-CHOP 21) chemotherapy as first-line therapy
- •Must have received an auto-SCT transplant after relapse
排除标准
- •Patients with low-grade lymphoma at presentation or relapse.
研究者
相似试验
尚未招募
不适用
Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Double Expressor LymphomaNCT06652152Ruijin Hospital400
已完成
2 期
Phase II randomised study of fludarabine/cyclophosphamide combination with or without rituximab in patients with untreated mantle cell lymphomaMantle cell lymphomaCancerISRCTN81133184niversity College London (UK)151
招募中
不适用
Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous NephropathyMembranous Nephropathy - PLA2R InducedNCT05679336St. Petersburg State Pavlov Medical University40
Unknown
3 期
R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell LymphomaLymphoma, Large B-Cell, DiffuseNCT02428751Wenqi Jiang216
已完成
2 期
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)Diffuse large B-cell lymphomaJPRN-UMIN000001050Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)40